161 related articles for article (PubMed ID: 1848009)
1. Effects of site-directed mutagenesis at residues cysteine-31 and cysteine-184 on lecithin-cholesterol acyltransferase activity.
Francone OL; Fielding CJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1716-20. PubMed ID: 1848009
[TBL] [Abstract][Full Text] [Related]
2. Roles of cysteines in human lecithin:cholesterol acyltransferase.
Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
Biochemistry; 1993 Mar; 32(12):3089-94. PubMed ID: 8457570
[TBL] [Abstract][Full Text] [Related]
3. Role of glutamic acid residues 154, 155, and 165 of lecithin:cholesterol acyltransferase in cholesterol esterification and phospholipase A2 activities.
Wang J; DeLozier JA; Gebre AK; Dolphin PJ; Parks JS
J Lipid Res; 1998 Jan; 39(1):51-8. PubMed ID: 9469585
[TBL] [Abstract][Full Text] [Related]
4. Effects of site-directed mutagenesis on the N-glycosylation sites of human lecithin:cholesterol acyltransferase.
Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
Biochemistry; 1993 Aug; 32(34):8732-6. PubMed ID: 8364023
[TBL] [Abstract][Full Text] [Related]
5. Effects of site-directed mutagenesis on the serine residues of human lecithin:cholesterol acyltransferase.
Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
Lipids; 1994 Dec; 29(12):803-9. PubMed ID: 7854004
[TBL] [Abstract][Full Text] [Related]
6. Lecithin:cholesterol acyltransferase: role of N-linked glycosylation in enzyme function.
O K; Hill JS; Wang X; McLeod R; Pritchard PH
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):879-84. PubMed ID: 8379944
[TBL] [Abstract][Full Text] [Related]
7. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
O K; Hill JS; Pritchard PH
Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
[TBL] [Abstract][Full Text] [Related]
8. Lecithin-cholesterol acyltransferase: effects of mutagenesis at N-linked oligosaccharide attachment sites on acyl acceptor specificity.
Francone OL; Evangelista L; Fielding CJ
Biochim Biophys Acta; 1993 Feb; 1166(2-3):301-4. PubMed ID: 8443248
[TBL] [Abstract][Full Text] [Related]
9. Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase.
Wang K; Subbaiah PV
Biochem J; 2002 Aug; 365(Pt 3):649-57. PubMed ID: 11966470
[TBL] [Abstract][Full Text] [Related]
10. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.
Vickaryous NK; Teh EM; Stewart B; Dolphin PJ; Too CK; McLeod RS
Biochim Biophys Acta; 2003 Mar; 1646(1-2):164-72. PubMed ID: 12637024
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships in human lecithin:cholesterol acyltransferase. Site-directed mutagenesis at serine residues 181 and 216.
Francone OL; Fielding CJ
Biochemistry; 1991 Oct; 30(42):10074-7. PubMed ID: 1931938
[TBL] [Abstract][Full Text] [Related]
12. Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344-->Ser).
Moriyama K; Sasaki J; Arakawa F; Takami N; Maeda E; Matsunaga A; Takada Y; Midorikawa K; Yanase T; Yoshino G
J Lipid Res; 1995 Nov; 36(11):2329-43. PubMed ID: 8656071
[TBL] [Abstract][Full Text] [Related]
13. Human plasma lecithin-cholesterol acyltransferase. An elucidation of the catalytic mechanism.
Jauhiainen M; Dolphin PJ
J Biol Chem; 1986 May; 261(15):7032-43. PubMed ID: 3700425
[TBL] [Abstract][Full Text] [Related]
14. Importance of the free sulfhydryl groups of lecithin-cholesterol acyltransferase for its sensitivity to oxidative inactivation.
Wang K; Subbaiah PV
Biochim Biophys Acta; 2000 Nov; 1488(3):268-77. PubMed ID: 11082536
[TBL] [Abstract][Full Text] [Related]
15. Human plasma lecithin-cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site.
Jauhiainen M; Stevenson KJ; Dolphin PJ
J Biol Chem; 1988 May; 263(14):6525-33. PubMed ID: 3129428
[TBL] [Abstract][Full Text] [Related]
16. Aromatic boronic acids as probes of the catalytic site of human plasma lecithin-cholesterol acyltransferase.
Jauhiainen M; Ridgway ND; Dolphin PJ
Biochim Biophys Acta; 1987 Apr; 918(2):175-88. PubMed ID: 3103690
[TBL] [Abstract][Full Text] [Related]
17. Lecithin cholesterol acyltransferase.
Jonas A
Biochim Biophys Acta; 2000 Dec; 1529(1-3):245-56. PubMed ID: 11111093
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation structure and enzyme activity of lecithin:cholesterol acyltransferase from human plasma, HepG2 cells, and baculoviral and Chinese hamster ovary cell expression systems.
Miller KR; Wang J; Sorci-Thomas M; Anderson RA; Parks JS
J Lipid Res; 1996 Mar; 37(3):551-61. PubMed ID: 8728318
[TBL] [Abstract][Full Text] [Related]
19. Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.
Freeman LA; Demosky SJ; Konaklieva M; Kuskovsky R; Aponte A; Ossoli AF; Gordon SM; Koby RF; Manthei KA; Shen M; Vaisman BL; Shamburek RD; Jadhav A; Calabresi L; Gucek M; Tesmer JJG; Levine RL; Remaley AT
J Pharmacol Exp Ther; 2017 Aug; 362(2):306-318. PubMed ID: 28576974
[TBL] [Abstract][Full Text] [Related]
20. Two different allelic mutations in a Finnish family with lecithin:cholesterol acyltransferase deficiency.
Miettinen H; Gylling H; Ulmanen I; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):460-7. PubMed ID: 7749857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
